Status | Study |
Enrolling by invitation |
Study Name: The Efficacy of Permethrin 5% Treatment for Demodex - Blepharitis in Comparison to Fucithalmic (Fusidic Acid 1%) and Synthomycine 5% Condition: Inflammation of the Eyelids Date: 2017-03-28 Interventions: Drug: Permethrin 5% Facial ski |
Recruiting |
Study Name: Comparison of BlephEx to MiBoflo as Treatment Options for Blepharitis Condition: Meibomian Gland Dysfunction Dry Eye Posterior Date: 2016-10-29 Interventions: Device: Blephex Lid margin exf |
Completed |
Study Name: Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% Condition: Chronic Blepharitis Date: 2014-09-08 Interventions: Drug: Ivermectin 0.1% Metronidazole 1% Other Name: 22,23-dihydroavermectin B1a + 22,23-dihydroavermectin |
Completed |
Study Name: Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease Condition: Blepharitis Date: 2014-08-13 Interventions: Drug: KPI-121 KPI-121 drug pro |
Completed |
Study Name: Oral Azithromycin Versus Doxycycline in Posterior Blepharitis Condition: Posterior Blepharitis Date: 2013-02-01 Interventions: Drug: Azithromycin Other Name: |
Completed |
Study Name: Demodex Blepharitis Treatment Study Condition: Chronic Blepharitis Date: 2012-07-12 Interventions: Drug: Terpinen-4-ol Lid scrub |
Terminated |
Study Name: Efficacy of Over the Counter (OTC) Povidone-Ioldine 5% for Treatment of Acute or Chronic Blepharitis Condition: Blepharitis Date: 2012-03-20 Interventions: Drug: povidone iodine Drug: Povidone-Iodin |
Not yet recruiting |
Study Name: Comparative Study to Evaluate ISV-305 Compared to Vehicle in Blepharitis Subjects Condition: Blepharitis Date: 2012-02-28 Interventions: Drug: ISV-305 Dexamethasone in |
Completed |
Study Name: Comparative Study in the Efficacy of Topical Besifloxocin With Erythromycin for the Management of Acute Blepharitis Condition: Blepharitis Date: 2011-11-21 Interventions: Drug: Erythromycin Topical ery |
Active, not recruiting |
Study Name: Efficacy of Zylet vs. Lotemax for the Treatment of Ocular Surface Inflammation/MGD/Blepharitis Condition: Meibomian Gland Dysfunction Posterior Blepharitis Date: 2011-08-02 Interventions: Drug: Loteprednol/tobramycin Z |